PARIS - Sanofi (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting April 1, 2024. Roger, who will be based in Paris, succeeds Jean-Baptiste Chasseloup de Chatillon, as he steps into a new role as Head of Apprentis d’Auteuil, a charitable foundation.
Roger brings a wealth of experience to Sanofi, having served as CFO at Nestle for more than eight years. His tenure there was marked by strong financial leadership and a commitment to sustainable value creation. Roger's extensive international experience includes positions across Europe, the U.S., Asia, Africa, and Latin America. Prior to Nestle, he was the CFO of Takeda Pharmaceuticals in Japan from 2013 to 2015. His career in the pharmaceutical industry began with a 14-year stint at Roussel, Hoechst, and Aventis, followed by roles at Danone Asia and the Danone Group, and later as CFO of Millicom, a NASDAQ-listed mobile phone operator.
Sanofi's CEO, Paul Hudson (NYSE:HUD), expressed confidence in Roger's appointment, noting his proven track record and the anticipated contribution to Sanofi's next phase of growth. Hudson also acknowledged the outgoing CFO, Chasseloup de Chatillon, for his role in advancing Sanofi's "Play to Win Strategy" and modernizing the finance organization.
Chasseloup de Chatillon reflected positively on his tenure at Sanofi, highlighting the company's transformation and his decision to join Apprentis d’Auteuil, driven by a passion for social impact. Roger, in turn, expressed enthusiasm for joining Sanofi during a significant period of transformation, aiming to enhance patient outcomes and shareholder value.
Sanofi is known for its commitment to improving lives through science, offering treatment options and vaccine protection globally. The company emphasizes sustainability and social responsibility in its operations. Sanofi's stock is traded on EURONEXT under the ticker SAN and on NASDAQ under the ticker SNY.
This leadership transition at Sanofi is based on a press release statement from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.